Indeed, ApoJ levels in LDL from AD patients were significantly higher than the corresponding levels in plasma from ICH-CAA patients when adjusted for the ApoE4 genotype (OR: 1.015 [1.002–1.027], p= 0.019) (Supplemental Table S4). The gene discussed is APOE; the disease is Alzheimer disease.